Auxilium completes patient enrollment in XIAFLEX phase III trial against Peyronie's disease
Links shared publicly online about this topic.
- 450total visits
Auxilium completes patient enrollment in XIAFLEX phase III trial against Peyronie's disease
Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced it has reached the target enrollment for the double-blind placebo-controlled phase III program of XIAFLEX for the treatment of Peyronie's disease.
View full resource at news-medical.net
Tags: Cancer, Prostate Cancer, Prostate, Disease and Condition, Pharma, Men's Health, disease
Most Recently Shared on March 10, 2011 at 5:38 am By:
Prostate Cancer: Auxilium completes patient enrollment in XIAFLEX phase III trial against Peyronie's disease: Au... http://bit.ly/fqegLv
Advertisement
